CEMI: Analysis & Opinions

  1. Q3: DPP Sales Up 49% Despite Revenue Miss - Analyst Blog

    November 13, 2012
    Q3: DPP Sales Up 49% Despite Revenue Miss  By Brian Marckx, CFA Q3 2012:  DPP Revenue Up 49%. Lateral Flow ...
  2. USPSTF Decision Could Benefit CEMI - Analyst Blog

    August 21, 2012
    USPSTF Decision Could Benefit CEMI A Reuters article yesterday (8/19/2012) notes that health officials with ...
  3. OSUR Approval Green-Light's CEMI's OTC Program? - ...

    July 05, 2012
    OSUR Approval Green-Light's CEMI's OTC Program? Brian Marckx, CFA OraSure's Rapid HIV FDA Approved For OTC ...
  4. CEMI: Study May Offer Support for DPP HCV Test - Analyst ...

    June 19, 2012
    CEMI: Study May Offer Support for DPP HCV Test Brian Marckx, CFA Results of a study in which IV drug users in ...
  5. CEMI: D??j?? vu: Another Record Quarter, Another ...

    May 09, 2012
    CEMI:  Déjà vu: Another Record Quarter, Another Top-line Beat   Brian Marckx, CFA Q1 2012: Record Revenue Beats ...
  6. CEMI: Deja vu: Another Record Quarter, Another Top-line ...

    May 09, 2012
    CEMI:  Déjà vu: Another Record Quarter, Another Top-line Beat   Brian Marckx, CFA Q1 2012: Record Revenue Beats ...
Marketplace
Trading Center